A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia

NCT03938922 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Compound will not be studied for indication

Conditions

Parkinson Disease
Dementia

Interventions

DRUG: Active Investigational Treatment ENT-01

Sponsor

Enterin Inc.